Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
PAR Technology
PAR
Concentration Risk %
Concentration Risk % at other companies
Gyre Therapeutics, Inc.
GYRE
93.1%
-5.3pp
Heartland Express
HTLD
32%
+6.0pp
Enovix Corporation
ENVX
83%
+36.0pp
Weis Markets
WMK
100%
0.0pp
Innoviva, Inc.
INVA
36%
+7.0pp
Strattec Security
STRT
0.5%
0.0pp
Segments
By segment
See full
Restaurant and Retail
25%
+31.6%
Other financials
Income statement
See full
Revenue
$124.0M
+19.4%
Gross profit
$54.5M
+12.7%
Operating income
-$13.9M
+11.8%
Net income
-$16.2M
+33.6%
EPS (diluted)
-$0.39
+35.0%
Balance sheet
See full
Cash & equivalents
$90.8M
-17.3%
Total debt
$433.8M
+3.3%
Total equity
$826.4M
-3.0%
Total assets
$1.4B
+0.7%
Cash flow
See full
Operating cash flow
-$16.6M
+3.1%
CapEx
$321.0K
-22.3%
Free cash flow
-$17.0M
+3.5%
Valuation
See full
Market cap
$656.64M
-74.4%
Enterprise value
$999.68M
-65.3%
P/S
1.4×
-5.3×
Profitability
See full
Gross margin
42.9%
-1.0pp
Operating margin
-14.1%
-2.4pp
Net margin
-16%
-20.5pp
FCF margin
-14.3%
-4.0pp
Returns & leverage
See full
Return on equity
-9.1%
-11.6pp
Debt / equity
0.5×
0.0×
Current ratio
2.1×
+0.1×